RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

Add to Collection
RCTs Y Ray, SR Paul, P Bandopadhyay, R D'Rozario… - Nature …, 2022 - nature.com

Chapter : Section15, Section25
Journal Year : 2022
Cited by : 29

… standard of care (as per guidelines of Indian Council of Medical Research) for the preceding … assessment, appropriate anti-diabetic therapy to maintain blood sugar below 200 mg/dl, anti…..... Read More

Keywords : ['phase single center open label randomise control trial', 'convalescent plasma therapy', 'severe', 'patient']
PubMed Link : https://www.nature.com/articles/s41467-022-28064-7
Google Scholar Link : https://scholar.google.com/scholar?cites=330701369133130180&as_sdt=20000005&sciodt=0,21&hl=en&num=20